The Effect of Rhodamine B on the Cerebellum and Brainstem Tissue of Rattus Norvegicus
Background Rhodamine B is a component of xenobiotic substance metabolized by cytochrome P450 in the body to produce free radicals, which affects the activity of Superoxidase Dismutase (SOD), thereby, leading to oxidative stress, injury, increase in cell apoptosis and brainstem. This study aims to de...
Saved in:
Published in | Journal of public health research Vol. 9; no. 2 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Pavia
PAGEPress Publications
03.07.2020
PAGEPress Publications, Pavia, Italy SAGE Publishing |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background Rhodamine B is a component of xenobiotic substance metabolized by cytochrome P450 in the body to produce free radicals, which affects the activity of Superoxidase Dismutase (SOD), thereby, leading to oxidative stress, injury, increase in cell apoptosis and brainstem. This study aims to determine the effect of Rhodamine B on BAX and BCL-2 in the cerebellum and brainstem tissue of Rattus norvegicus. Design and methods The True Experimental Design was used to carry out a post-test examination on the control group of twenty-eight Wistar female Rattus norvegicus mice between the ages of 10-12 weeks. Then, samples were categorized into 4 groups in body weight doses of 4.5 mg/200g, 9 mg/200g, and 18 mg/200g. They were administrated with Rhodamine B personde for 36 days. Results The results showed that Rhodamine B had a direct and indirect effect on BAX and BCL-2 expressions, respectively, in the cerebellum tissue and wistar strain of Rattus norvegicus. In addition, the positive path coefficient of BAX expression has a positive effect on BCL-2. This means that an increase in BAX has a direct impact on decreasing BCL-2 expression in cerebellum tissue and brainstem of Rattus norvegicus wistar strain along with an increased dose of Rhodamine B. Conclusions In conclusion, Rhodamine B tends to increase BAX expression which directly decreases BCL-2 in Cerebellum tissue and Brainstem in Rattus norvegicus along with increasing doses. |
---|---|
Bibliography: | Conference presentation: Part of this paper was presented at the 4rd International Symposium of Public Health, from Oct 29–31, 2019, at Griffith University, Gold Coast, Brisbane, Queensland, Australia. Clinical trials: This research has been approved by the Research Ethics Committee of The Faculty of Medicine University of Brawijaya, Malang, Indonesia Contributions: The authors contributed equally. Conflict of interest: The authors declare no potential conflict of interest. |
ISSN: | 2279-9036 2279-9028 2279-9036 |
DOI: | 10.4081/jphr.2020.1812 |